For instance, GANT61 has exhibited specific antitumor effects by suppressing GLI expression in models of lung cancer xenografts, acute myeloid leukemia, rhabdomyosarcoma (RMS), neuroblastoma (NB), breast cancer, and pancreatic cancer [37–43]. This evidence concerns the gene GLI1 and acute myeloid leukemia.